304 related articles for article (PubMed ID: 30722781)
1. Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours.
Youshani AS; Rowlston S; O'Leary C; Forte G; Parker H; Liao A; Telfer B; Williams K; Kamaly-Asl ID; Bigger BW
J Neuroinflammation; 2019 Feb; 16(1):25. PubMed ID: 30722781
[TBL] [Abstract][Full Text] [Related]
2. Busulfan as a myelosuppressive agent for generating stable high-level bone marrow chimerism in mice.
Peake K; Manning J; Lewis CA; Barr C; Rossi F; Krieger C
J Vis Exp; 2015 Apr; (98):e52553. PubMed ID: 25867947
[TBL] [Abstract][Full Text] [Related]
3. A nonmyeloablative chimeric mouse model accurately defines microglia and macrophage contribution in glioma.
Yu K; Youshani AS; Wilkinson FL; O'Leary C; Cook P; Laaniste L; Liao A; Mosses D; Waugh C; Shorrock H; Pathmanaban O; Macdonald A; Kamaly-Asl I; Roncaroli F; Bigger BW
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):119-140. PubMed ID: 29679380
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow cell recruitment to the brain in the absence of irradiation or parabiosis bias.
Kierdorf K; Katzmarski N; Haas CA; Prinz M
PLoS One; 2013; 8(3):e58544. PubMed ID: 23526995
[TBL] [Abstract][Full Text] [Related]
5. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
Down JD; Ploemacher RE
Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
[TBL] [Abstract][Full Text] [Related]
6. Busulfan-conditioned bone marrow transplantation results in high-level allogeneic chimerism in mice made tolerant by in utero hematopoietic cell transplantation.
Ashizuka S; Peranteau WH; Hayashi S; Flake AW
Exp Hematol; 2006 Mar; 34(3):359-68. PubMed ID: 16543070
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
8. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts.
Lapidot T; Terenzi A; Singer TS; Salomon O; Reisner Y
Blood; 1989 May; 73(7):2025-32. PubMed ID: 2653469
[TBL] [Abstract][Full Text] [Related]
9. Effects of myeloablation, peripheral chimerism, and whole-body irradiation on the entry of bone marrow-derived cells into the brain.
Lampron A; Lessard M; Rivest S
Cell Transplant; 2012; 21(6):1149-59. PubMed ID: 21944997
[TBL] [Abstract][Full Text] [Related]
10. Lymphoid reconstitution after transplantation of congenic hematopoietic cells in busulfan-treated mice.
Yeager AM; Shinn C; Pardoll DM
Blood; 1991 Dec; 78(12):3312-6. PubMed ID: 1683798
[TBL] [Abstract][Full Text] [Related]
11. Comparison of gamma and x-ray irradiation for myeloablation and establishment of normal and autoimmune syngeneic bone marrow chimeras.
Wittenborn TR; Fahlquist Hagert C; Ferapontov A; Fonager S; Jensen L; Winther G; Degn SE
PLoS One; 2021; 16(3):e0247501. PubMed ID: 33730087
[TBL] [Abstract][Full Text] [Related]
12. Targeting myeloid cells to the brain using non-myeloablative conditioning.
Böttcher C; Fernández-Klett F; Gladow N; Rolfes S; Priller J
PLoS One; 2013; 8(11):e80260. PubMed ID: 24244666
[TBL] [Abstract][Full Text] [Related]
13. Myelosuppressive conditioning using busulfan enables bone marrow cell accumulation in the spinal cord of a mouse model of amyotrophic lateral sclerosis.
Lewis CA; Manning J; Barr C; Peake K; Humphries RK; Rossi F; Krieger C
PLoS One; 2013; 8(4):e60661. PubMed ID: 23593276
[TBL] [Abstract][Full Text] [Related]
14. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS
Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
[TBL] [Abstract][Full Text] [Related]
15. Proliferation kinetics of immune cells during early phase of bone marrow transplantation in mouse model based on chemotherapy conditioning.
Chen C; DA Z; Lu Y; Zhou J; Li X; Fu B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 May; 46(5):449-457. PubMed ID: 34148880
[TBL] [Abstract][Full Text] [Related]
16. Signal one and two blockade are both critical for non-myeloablative murine HSCT across a major histocompatibility complex barrier.
Langford-Smith KJ; Sandiford Z; Langford-Smith A; Wilkinson FL; Jones SA; Wraith JE; Wynn RF; Bigger BW
PLoS One; 2013; 8(10):e77632. PubMed ID: 24147041
[TBL] [Abstract][Full Text] [Related]
17. Conditions of retinal glial and inflammatory cell activation after irradiation in a GFP-chimeric mouse model.
Müther PS; Semkova I; Schmidt K; Abari E; Kuebbeler M; Beyer M; Abken H; Meyer KL; Kociok N; Joussen AM
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4831-9. PubMed ID: 20435601
[TBL] [Abstract][Full Text] [Related]
18. Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers.
van Pel M; van Breugel DW; Vos W; Ploemacher RE; Boog CJ
Bone Marrow Transplant; 2003 Jul; 32(1):15-22. PubMed ID: 12815473
[TBL] [Abstract][Full Text] [Related]
19. In vivo imaging studies of the effect of recipient conditioning, donor cell phenotype and antigen disparity on homing of haematopoietic cells to the bone marrow.
Askenasy N; Farkas DL
Br J Haematol; 2003 Feb; 120(3):505-15. PubMed ID: 12580970
[TBL] [Abstract][Full Text] [Related]
20. Cardiac allograft acceptance after localized bone marrow transplantation by isolated limb perfusion in nonmyeloablated recipients.
Askenasy N; Yolcu ES; Shirwan H; Wang Z; Farkas DL
Stem Cells; 2003; 21(2):200-7. PubMed ID: 12634416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
